Kirklin J K, Blackstone E H, Kirklin J W
Blood Purif. 1987;5(2-3):168-78. doi: 10.1159/000169466.
Despite the widespread safe application of cardiopulmonary bypass (CPB) for cardiac surgery, it is inherently a pathologic state. CPB produces a generalized inflammatory reaction involving at least the complement, coagulation, kallikrein, and fibrinolytic cascades. Marked alterations in organ perfusion and metabolism occur during CPB which are further affected by the perfusion flow rate. During hypothermic CPB at 20 degrees C, there is a progressive decrease in perfusion of the microcirculation at flow rates less than 1.2 liters/min/m2. Experimental studies suggest that brain oxygen consumption and resistance remain relatively constant as flow rates are reduced during hypothermia, and the brain becomes the passive recipient of proportionally more blood flow. Recent ultrafiltration studies have demonstrated a specific increase in microvascular permeability to proteins after 2 h of normothermic CPB. This provides experimental support to the well-known clinical observation of increased interstitial fluid following CPB. The development of uniformly safe CPB depends upon prevention of the abnormalities of the microcirculation and upon neutralization of the deleterious effects of inflammatory mediators.
尽管心肺转流术(CPB)在心脏手术中得到了广泛的安全应用,但它本质上是一种病理状态。CPB会引发全身性炎症反应,至少涉及补体、凝血、激肽释放酶和纤溶级联反应。在CPB期间,器官灌注和代谢会发生显著变化,而灌注流速会进一步影响这些变化。在20摄氏度的低温CPB期间,当流速低于1.2升/分钟/平方米时,微循环灌注会逐渐减少。实验研究表明,在低温期间随着流速降低,脑氧消耗和阻力保持相对恒定,并且脑会成为比例上更多血流的被动接受者。最近的超滤研究表明,常温CPB 2小时后微血管对蛋白质的通透性会特异性增加。这为CPB后间质液增加这一众所周知的临床观察结果提供了实验支持。安全的CPB的发展取决于预防微循环异常以及中和炎症介质的有害作用。